Yogaros 10 Tablet contains Rosuvastatin 10 mg, a potent lipid-lowering agent belonging to the statin class of medications. It is primarily indicated for the treatment of hypercholesterolemia and mixed dyslipidemia to reduce elevated levels of total cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglycerides, while modestly increasing high-density lipoprotein cholesterol (HDL-C). Rosuvastatin exerts its effect by selectively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, leading to decreased cholesterol production in the liver and increased clearance of LDL-C from the bloodstream. Yogaros 10 is prescribed to patients at high risk of cardiovascular events, including those with a history of coronary artery disease, stroke, or peripheral arterial disease, to lower the risk of myocardial infarction and related complications. The medication is administered orally, typically once daily, with or without food, and dosage adjustments may be required based on therapeutic response and patient tolerance. Common adverse effects include headache, myalgia, and gastrointestinal disturbances, while rare but serious risks involve myopathy and hepatotoxicity, necessitating periodic monitoring of liver function tests and creatine kinase levels. Yogaros 10 should be used with caution in patients with pre-existing liver disease or renal impairment and is contraindicated during pregnancy and lactation.